Insights

Meet Zylidac: A New CDMO with Forty-Plus Years of Experience

Zylidac is a new CDMO subsidiary of India-based biopharma company Zydus Lifesciences. Although launched in early 2026, the Zylidac team has over four decades of experience shepherding biologic therapeutics, including antibodies, bispecifics, and fusion proteins, from preclinical development to commercial production. At its state-of-the-art facility in Emeryville, CA, Zylidac supports clients from cell-line development through…